
    
      1. To investigate pharmacokinetic and pharmacodynamic characteristics of Temanogrel when
           orally co-administered with Aspirin and/or Clopidogrel in healthy subject. a person
           determined to be suitable for the purpose of this clinical trial by investigator with
           consideration for the age and the health status of a volunteer is selected

        2. Assess the safety of Temanogrel when orally co-administered with Aspirin and/or
           Clopidogrel in healthy subjects.
    
  